Handelsavisen
prelaunch
Companies Industrials SERA.BO
SE
SERA.BO BSE (India) Industrial Support Services

Sera.Bo

$46,12
Open in Charts → Attach watcher ⌖
USD
Set alert
Last 30 days
1D5D1M3M6MYTD1Y5YMax
Live price chart loads from the market-data widget.
Mcap
P/E
EV / Rev
Div yield
Op margin
22,4 %
ROE
0,9 %
Net margin
21,8 %
Debt / equity
0,07
Beta
52w range
Volume
Day range
Prev close
$2,14
Open
Next earnings
2026-10-28
Ex-dividend
TR 1Y
About

SERA.BO operates in the investment banking and brokerage services sector, generating revenue primarily through financial advisory, asset management, and brokerage commissions.

Business. Sera Prognostics Inc (SERA.O) is a business support services company operating within the Industrial & Commercial Services sector. The firm generates service revenue through industrial services activities. Headquarters and specific operating segment details are not provided in the available data. The company is listed on the NASDAQ stock exchange.

Classification99 %
SectorIndustrials
Industry groupIndustrial Support Services
Generated · model-assisted
Sell-side consensus
BUY3 analysts
3 buy0 hold0 sell
Avg 12m price target5,00

Analyst recommendations

3 analysts · consensus Buy
Buy3
Hold0
Sell0
12-month price target
5,00
Consensus of sell-side coverage.
Upcoming events
  • EarningsQ3 2026 earnings (expected)2026-10-28 · estimated
See all catalysts →

At a glance

Score
not yet scored
Valuation
valuation pending
Analysts
Buy
3 analysts · indicative
Ownership
BlackRock Institutional Trust Company, N.A.
largest disclosed fund holder
Profitability
0,9 %
return on equity
Quality
not yet scored

What drives this business

The watch-list the newsroom runs for this company — derived from its sector path, sharpened layer by layer. Not investment advice.

— missing data

News & coverage

0
  • No recent newsroom coverage mentioning SERA.
  • Sector rotation

    Sector1D1Mvs mkt
    Materials+2,3 %+6,6 %+1,7 %
    Communication Services+2,2 %−5,5 %+1,6 %
    Energy+0,6 %+3,3 %+0,0 %
    Health Care+0,6 %−0,8 %+0,0 %
    Information Technology+0,6 %+6,7 %+0,0 %
    Consumer Discretionary+0,4 %+7,6 %−0,2 %
    Financials−0,3 %−2,8 %−0,9 %
    Consumer Staples−0,4 %+2,5 %−1,0 %
    Real Estate−0,7 %+10,9 %−1,3 %
    Industrials · THIS SECTOR−1,9 %−3,1 %−2,5 %
    Utilities−1,9 %+28,2 %−2,5 %

    Developing storylines

    No tracked sagas currently linked to SERA.BO. Browse all sagas →

    Analysis

    AI analysis
    Generated · analysis pipeline · tier hybrid · as of 2026-08-04 ↑ At a glance

    Opportunity

    — missing data

    Upcoming catalysts

    Scheduled public events. Informational only — not investment advice.

    • Company
    • EarningsQ3 2026 earnings (expected)2026-10-28 · estimated
    • Macro
    • Rate decisionBank of England rate decision (press conf.)2026-08-06 · GB
    • Rate decisionReserve Bank of Australia rate decision (press conf.)2026-08-12 · AU
    • Rate decisionNorges Bank rate decision (press conf.)2026-08-20 · NO
    • Rate decisionSveriges Riksbank rate decision (press conf.)2026-09-03 · SE
    • Rate decisionBank of Canada rate decision (press conf.)2026-09-09 · CA
    • Rate decisionEuropean Central Bank rate decision (press conf.)2026-09-10 · EU
    • Macro & political
    • ElectionSE Swedish Election2026-09-14 · SE
    • ElectionUS U.S. Midterms2026-11-03 · US
    • ElectionFR French Legislative2027-06-01 · FR

    Pre-earnings brief

    — missing data

    Signals & dispatch

    peak dispatch · —

    Composite-score breakdown

    Synthesis

    Business

    Sera Prognostics Inc (SERA.O) is a business support services company operating within the Industrial & Commercial Services sector. The firm generates service revenue through industrial services activities. Headquarters and specific operating segment details are not provided in the available data. The company is listed on the NASDAQ stock exchange.

    Classification99 %
    SectorIndustrials
    Industry groupIndustrial Support Services
    AI synthesis
    GENERATED

    SERA.BO maintains a strong liquidity position, with cash and equivalents amounting to INR 267.24 million, representing 7.0% of total assets. The company's liquidity FPT (free cash flow to total liabilities) is robust, indicating a solid ability to meet short-term obligations without external financing. The debt-to-equity ratio of 0.07 suggests a conservative capital structure, with minimal reliance on debt financing.

    Profitability metrics for SERA.BO show a return on equity (ROE) of 0.86% and a return on assets (ROA) of 0.66%. These figures are below the industry median for investment banking and brokerage services, indicating that the company is underperforming in terms of asset and equity utilization. The net income margin of 21.8% is relatively strong, but the operating margin of 22.4% suggests that operating expenses are consuming a significant portion of gross profit.

    The company's revenue is concentrated in a single business segment, with no disclosed geographic diversification. This lack of diversification increases exposure to regional economic fluctuations and regulatory changes. The absence of segment-specific data limits the ability to assess the performance of individual business lines.

    SERA.BO's growth trajectory is modest, with revenue of INR 115.89 million in the latest reporting period. The outlook for the current fiscal year indicates a slight increase in revenue, but the magnitude of the growth is not specified. The company's capital expenditure of INR -11.84 million suggests a reduction in investment in physical assets, which may indicate a focus on cost optimization or a shift toward digital transformation.

    Risk factors for SERA.BO include low liquidity and dilution risk, with no immediate filing-based flags detected. The company's conservative debt structure and strong cash reserves mitigate liquidity concerns. However, the low ROE and ROA highlight the need for operational improvements to enhance profitability. The absence of dilution risk is a positive sign, but the company's reliance on a single revenue stream remains a concentration risk.

    Recent events for SERA.BO include the latest financial filing, which provides updated financial metrics and confirms the company's current operational status. No significant regulatory or legal events were disclosed in the latest reports. The company's focus on maintaining a strong liquidity position and conservative capital structure is evident from the financial data.

    Key takeaways
    • SERA.BO maintains a conservative capital structure with a low debt-to-equity ratio of 0.07.
    • The company's ROE of 0.86% and ROA of 0.66% indicate underperformance relative to industry medians.
    • Revenue is concentrated in a single business segment, increasing exposure to regional and regulatory risks.
    • The company's liquidity position is strong, with cash and equivalents representing 7.0% of total assets.
    • No immediate liquidity or dilution risks were detected, but operational improvements are needed to enhance profitability.

    Bull / Bear case

    Generated · model-assisted
    — missing data

    In focus — financials by report

    Valuation

    Market price
    $46,12
    Market cap
    Enterprise value
    P/E
    Non-GAAP P/E
    EV / Revenue
    EV / Op income
    EV / OCF
    P / B
    P / Tangible book
    Tangible book
    $2.94B
    Net cash
    $67.3M
    Current ratio
    Debt / equity
    0.1
    ROA
    0.7%
    ROE
    0.9%
    Cash conversion
    382.0%
    CapEx / revenue
    -10.2%
    SBC / revenue
    Dilution ratio
    0.0%

    Revenue by segment

    Market share

    INDUSTRYSEGMENTCOMPANYIndustrialsIndustryIndustrial Support Services31,7B node revenueRTO 21,8%FCN 11,9%ROL 11,8%URI 11,6%ULS 9,6%GEO 8,3%EQPT 6,4%TIC 4,8%Other 13,6%
    Source: company disclosures · own-taxonomy revenue-covered set · attribution: collision-suspect (indicative)SERA 0,0% · rank #28 of 31

    Business relationships

    — missing data

    Supply chain

    — missing data

    Peer comparison

    Peer comparison8 peers · vs SERA · multiples and returns
    RT
    RTO
    Rentokil Initial PLC
    P/E
    vs self
    Div yield
    vs self
    ROE
    vs self
    FC
    FCN
    Fti Consulting Inc
    P/E
    vs self
    Div yield
    vs self
    ROE
    vs self
    RO
    ROL
    Rollins Inc
    $38,19
    18,4B USD
    P/E
    36,0x
    vs self
    Div yield
    1,7 %
    vs self
    ROE
    38,1 %
    +80,5 vs self
    UR
    URI
    United Rentals Inc
    $1 115,92
    70,3B USD
    P/E
    28,6x
    vs self
    Div yield
    0,6 %
    vs self
    ROE
    27,8 %
    +70,2 vs self
    UL
    ULS
    Ul Solutions Inc
    $91,05
    18,3B USD
    P/E
    57,3x
    vs self
    Div yield
    0,6 %
    vs self
    ROE
    25,8 %
    +68,1 vs self
    GE
    GEO
    Geo Group Inc
    P/E
    vs self
    Div yield
    vs self
    ROE
    vs self
    EQ
    EQPT
    Equipmentshare.Com Inc
    $20,20
    4,6B USD
    P/E
    126,5x
    vs self
    Div yield
    vs self
    ROE
    3,3 %
    +45,7 vs self
    TI
    TIC
    Tic Solutions Inc
    P/E
    vs self
    Div yield
    vs self
    ROE
    vs self

    Market position

    Stress test

    — missing data

    Predictor forecast

    Next quarternear-term
    Earnings · next quarterconf 45 %
    EPS
    Consensus EPS
    -0,67
    Predicted surprise
    +0,00
    Beat probability
    45 %
    Analysts
    3
    Other metrics
    Revenue
    no estimate
    Segment revenue
    no estimate
    Margin
    no estimate
    Segment margin
    no estimate
    as of 2026-05-16 · Earnings Surprise V1
    Period note: consensus is not fiscal-period-aligned at source — read as consensus vs the last reported actual, not a calibrated same-quarter surprise.
    Probabilistic model output — not investment advice. · generated 2026-08-04

    Options

    — missing data

    Short squeeze

    — missing data

    Earnings-call key lines

    — missing data

    Estimate revisions

    consensus EPS · 26-week trend
    — missing data

    Sell-side observations

    Low$5,00
    Mean$5,00
    Median$5,00
    High$5,00
    Spot$46,12
    −89.2 %implied to mean12-month sell-side price targets · ▲ spot

    Themes

    — missing data

    ESG

    — missing data

    Risk factors

    Dilution riskLow
    Liquidity riskLow
    Filing-based flags
    • No immediate filing-based liquidity or dilution flags were detected.

    Benchmarks vs cohort

    Op Margin22,4 %Above P75
    Net Margin21,8 %Above P75
    ROE0,9 %Above median
    Capex / Rev-10,2 %Below median
    D/E0,07Above median
    Cash Conv3,82Best in class

    Corporate actions / M&A

    — missing data

    FX exposure

    — missing data

    Comparable transactions

    — missing data

    Derivatives & instruments

    Derivative transactions

    Net acquired 422 886 sh5 grants5 insiders
    • Jackson BenjaminGeneral Counsel · Stock Option (right to buy) → Class A Common StockAcquired 68 550 @ $1,99grant · 2026-03-12
    • Aerts AustinChief Financial Officer · Stock Option (right to buy) → Class A Common StockAcquired 68 550 @ $1,99grant · 2026-03-12
    • Anderson Dyaarl Lee Jr.Chief Commercial Officer · Stock Option (right to buy) → Class A Common StockAcquired 19 310 @ $1,99grant · 2026-03-12
    • Inglis Tiffany Eul DavisChief Medical Officer · Stock Option (right to buy) → Class A Common StockAcquired 27 034 @ $1,99grant · 2026-03-12
    • Lindgardt ZhenyaDirector, Chief Executive Officer · Stock Option (right to buy) → Class A Common StockAcquired 239 442 @ $1,99grant · 2026-03-12

    Actions

    Ask Handelsavisen

    — missing data
    Data sources
    • Market data
    • Market data cache
    • Issuer disclosures
    • Public news
    • Earnings transcripts
    • Consensus estimates
    • ESG data
    How metrics are computed
    • Dilution Ratio
      (shares_outstanding_diluted - shares_outstanding_basic) / shares_outstanding_basic
    • Net Cash
      cash_and_equivalents + short_term_investments - short_term_debt - long_term_debt
    • Capex To Revenue
      capital_expenditure / revenue
    • Return On Equity
      net_income / total_equity
    • Debt To Equity
      (short_term_debt + long_term_debt) / total_equity
    • Cash Conversion Ratio
      operating_cash_flow / net_income
    Source documents
    • SERA.BO Market data — financials · 2026-05-29

    Ownership & reference

    Top holders

    • BlackRock Institutional Trust Company, N.A.Investment Managers · as of 2024-06-300,00 %$8M
    • Nuveen LLCInvestment Managers · as of 2024-12-310,00 %$0M
    • Vanguard Capital Management, LLCInvestment Managers · as of 2025-12-310,00 %$4M
    • Geode Capital Management, L.L.C.Investment Managers · as of 2026-03-310,00 %$1M
    • Northern Trust Investments, Inc.Investment Managers · as of 2026-03-310,00 %$0M
    • Bank of New York Mellon CorpInstitutional Investor · as of 2026-03-310,00 %$0M
    • Morgan Stanley Smith Barney LLCInvestment Managers · as of 2026-03-310,00 %$0M
    • State Street Investment Management (US)Investment Managers · as of 2026-03-310,00 %$0M
    • Dimensional Fund Advisors, L.P.Investment Managers · as of 2026-03-310,00 %$0M
    • UBS Financial Services, Inc.Investment Managers · as of 2026-03-310,00 %$0M
    • Goldman Sachs Asset Management, L.P.Investment Managers · as of 2026-03-310,00 %$0M
    • Charles Schwab Investment Management, Inc.Investment Managers · as of 2026-03-310,00 %$0M
    • FMR LLCInstitutional Investor · as of 2026-03-310,00 %$0M

    Insider activity

    Net selling0 buys · 16 sellsnet -$163K9 insiders · last 365d
    • Jackson BenjaminGeneral Counsel · Class A Common StockSold 2 179 @ $2,01$4K · 2026-06-11
    • Anderson Dyaarl Lee Jr.Chief Commercial Officer · Class A Common StockSold 4 739 @ $2,01$10K · 2026-06-11
    • Aerts AustinChief Financial Officer · Class A Common StockSold 2 037 @ $2,01$4K · 2026-06-11
    • Lindgardt ZhenyaDirector, Chief Executive Officer · Class A Common StockSold 6 990 @ $2,01$14K · 2026-06-11
    • Inglis Tiffany Eul DavisChief Medical Officer · Class A Common StockSold 362 @ $2,01$728 · 2026-06-11
    • Lindgardt ZhenyaDirector, Chief Executive Officer · Class A Common StockSold 20 755 @ $2,08$43K · 2026-06-09
    • Aerts AustinChief Financial Officer · Class A Common StockSold 5 440 @ $2,08$11K · 2026-06-09
    • Lawrence Sandra AJDirector · Class A Common StockSold 1 560 @ $2,15$3K · 2026-06-08
    • Anderson Dyaarl Lee Jr.Chief Commercial Officer · Class A Common StockOther 3 168 @ $1,84$6K · 2026-05-29
    • Jackson BenjaminGeneral Counsel · Class A Common StockOther 5 000 @ $1,84$9K · 2026-05-29
    • Anderson Dyaarl Lee Jr.Chief Commercial Officer · Class A Common StockOther 12 455 · 2026-03-12
    • Lindgardt ZhenyaDirector, Chief Executive Officer · Class A Common StockOther 154 440 · 2026-03-12
    • Jackson BenjaminGeneral Counsel · Class A Common StockOther 44 215 · 2026-03-12
    • Inglis Tiffany Eul DavisChief Medical Officer · Class A Common StockOther 17 437 · 2026-03-12
    • Aerts AustinChief Financial Officer · Class A Common StockOther 44 215 · 2026-03-12
    • Aerts AustinChief Financial Officer · Class A Common StockSold 1 019 @ $2,04$2K · 2026-03-11
    • Jackson BenjaminGeneral Counsel · Class A Common StockSold 1 027 @ $2,04$2K · 2026-03-11
    • Harrison Robert GardnerChief Information Officer · Class A Common StockSold 716 @ $2,04$1K · 2026-03-11
    • Boniface John J.Chief Scientific Officer · Class A Common StockSold 1 517 @ $2,04$3K · 2026-03-11
    • Lindgardt ZhenyaDirector, Chief Executive Officer · Class A Common StockSold 2 973 @ $2,04$6K · 2026-03-11
    • Kearney PaulChief Data Officer · Class A Common StockSold 1 396 @ $2,04$3K · 2026-03-11
    • Lindgardt ZhenyaDirector, Chief Executive Officer · Class A Common StockSold 22 639 @ $1,90$43K · 2026-03-10
    • Aerts AustinChief Financial Officer · Class A Common StockSold 6 069 @ $1,90$12K · 2026-03-10

    Short positioning

    240.8Kshares short-8.3% vs prior
    6.83days to cover
    82.1%short of daily vol
    2.0Kfails-to-deliver
    as of 2026-07-15 · short-interest report (free)

    Geographic breakdown

    — missing data
    Listings · one canonical issuer all listings resolve to the canonical
    SERA.BOCanonical
    BSE (India) · USD

    Intel & risk

    PredictorBeat prob45 %Surprise+0,00Full forecast →
    peak dispatch · —
    OSINT findings
    Dilution riskLow
    Liquidity riskLow
    No immediate filing-based liquidity or dilution flags were detected.

    Evidence & claims

    From filings & derived data
    • EPS (basic) (YoY) (2025-12-31 vs 2024-12-31): 32.3%Derived (calculated)
    • Net margin (FY 2025-12-31): -39,417.3%Derived (calculated)
    • Return on equity (FY 2025-12-31): -42.3%Derived (calculated)
    • Return on assets (FY 2025-12-31): -31.3%Derived (calculated)
    • Current ratio (FY 2025-12-31): 1.69xDerived (calculated)
    • Debt-to-equity (FY 2025-12-31): 0.35xDerived (calculated)
    • Capex (YoY) (2025-12-31 vs 2024-12-31): 1,196.4%Derived (calculated)
    • Cash & equivalents (YoY) (2025-12-31 vs 2024-12-31): -2.4%Derived (calculated)
    • EPS (diluted) (YoY) (2025-12-31 vs 2024-12-31): 32.3%Derived (calculated)
    • Net income (YoY) (2025-12-31 vs 2024-12-31): 2.9%Derived (calculated)
    • Operating cash flow (YoY) (2025-12-31 vs 2024-12-31): -80.6%Derived (calculated)
    • Operating income (YoY) (2025-12-31 vs 2024-12-31): 0.4%Derived (calculated)
    • R&D expense (YoY) (2025-12-31 vs 2024-12-31): -10.6%Derived (calculated)
    • Revenue (YoY) (2025-12-31 vs 2024-12-31): 5.2%Derived (calculated)
    • Shareholders' equity (YoY) (2025-12-31 vs 2024-12-31): 57.7%Derived (calculated)
    • Total assets (YoY) (2025-12-31 vs 2024-12-31): 40.5%Derived (calculated)
    • Total liabilities (YoY) (2025-12-31 vs 2024-12-31): 7.1%Derived (calculated)
    • Cost of revenue (YoY) (2025-12-31 vs 2024-12-31): 100.0%Derived (calculated)
    • Total operating expenses (annual): USD 36.59MSEC XBRL filing
    • Pre-tax income (annual): USD -31.93MSEC XBRL filing
    • EPS (diluted) (annual): USD-PER-SHARES -1SEC XBRL filing
    • Cost of revenue (annual): USD 164KSEC XBRL filing
    • Total liabilities (annual): USD 26.52MSEC XBRL filing
    • Cash & equivalents (annual): USD 3.94MSEC XBRL filing
    Showing 24 of 60 surfaced claims.
    Atomic claims from regulatory filings and derived calculations. Provenance shown as source kind only.

    The Thread

    Everything we know, in order
    2026-10-28EVENTUpcomingQ3 2026 earnings (expected) estimated date
    2026-06-30 03:38 UTCEARNINGSUpcomingForecast: insider_flow_signal (90d)
    2026-06-30 03:38 UTCEARNINGSUpcomingForecast: earnings_forecast (90d)
    2026-06-11 00:00 UTCINSIDER8 insider transactions — 2026-06
    2026-06-11INSIDERJackson Benjamin sold 2.2k sh Class A Common Stock — General Counsel ~$4k
    2026-06-11INSIDERAnderson Dyaarl Lee Jr. sold 4.7k sh Class A Common Stock — Chief Commercial Officer ~$10k
    2026-06-11INSIDERAerts Austin sold 2.0k sh Class A Common Stock — Chief Financial Officer ~$4k
    2026-06-11INSIDERLindgardt Zhenya sold 7.0k sh Class A Common Stock — Director, Chief Executive Officer ~$14k
    2026-06-11INSIDERInglis Tiffany Eul Davis sold 362 sh Class A Common Stock — Chief Medical Officer ~$1k
    2026-06-09INSIDERLindgardt Zhenya sold 20.8k sh Class A Common Stock — Director, Chief Executive Officer ~$43k
    2026-06-09INSIDERAerts Austin sold 5.4k sh Class A Common Stock — Chief Financial Officer ~$11k
    2026-06-08INSIDERLawrence Sandra AJ sold 1.6k sh Class A Common Stock — Director ~$3k
    2026-06-04FILING8-K filing →
    2026-06-01FILING8-K filing →
    2026-05-29 00:00 UTCINSIDER2 insider transactions — 2026-05
    2026-05-29INSIDERAnderson Dyaarl Lee Jr. transacted 3.2k sh Class A Common Stock — Chief Commercial Officer ~$6k
    2026-05-29INSIDERJackson Benjamin transacted 5.0k sh Class A Common Stock — General Counsel ~$9k
    2026-05-06FILING10-Q filing →
    2026-05-06FILING8-K filing →
    2026-04-24FILINGDEF 14A filing →
    2026-03-18FILING424B5 filing →
    2026-03-18FILING10-K filing →
    2026-03-18FILING8-K filing →
    2026-03-12 00:00 UTCINSIDER18 insider transactions — 2026-03 5 derivative
    2026-03-12INSIDERAnderson Dyaarl Lee Jr. transacted 12.5k sh Class A Common Stock — Chief Commercial Officer
    2026-03-12INSIDERLindgardt Zhenya transacted 154.4k sh Class A Common Stock — Director, Chief Executive Officer
    2026-03-12INSIDERJackson Benjamin transacted 44.2k sh Class A Common Stock — General Counsel
    2026-03-12INSIDERInglis Tiffany Eul Davis transacted 17.4k sh Class A Common Stock — Chief Medical Officer
    2026-03-12INSIDERAerts Austin transacted 44.2k sh Class A Common Stock — Chief Financial Officer
    2026-03-12INSIDERLindgardt Zhenya acquired 239.4k sh Stock Option (right to buy) — Director, Chief Executive Officer
    2026-03-12INSIDERJackson Benjamin acquired 68.5k sh Stock Option (right to buy) — General Counsel
    2026-03-12INSIDERInglis Tiffany Eul Davis acquired 27.0k sh Stock Option (right to buy) — Chief Medical Officer
    2026-03-12INSIDERAnderson Dyaarl Lee Jr. acquired 19.3k sh Stock Option (right to buy) — Chief Commercial Officer
    2026-03-12INSIDERAerts Austin acquired 68.5k sh Stock Option (right to buy) — Chief Financial Officer
    2026-03-11INSIDERAerts Austin sold 1.0k sh Class A Common Stock — Chief Financial Officer ~$2k
    2026-03-11INSIDERJackson Benjamin sold 1.0k sh Class A Common Stock — General Counsel ~$2k
    2026-03-11INSIDERHarrison Robert Gardner sold 716 sh Class A Common Stock — Chief Information Officer ~$1k
    2026-03-11INSIDERBoniface John J. sold 1.5k sh Class A Common Stock — Chief Scientific Officer ~$3k
    2026-03-11INSIDERLindgardt Zhenya sold 3.0k sh Class A Common Stock — Director, Chief Executive Officer ~$6k
    2026-03-11INSIDERKearney Paul sold 1.4k sh Class A Common Stock — Chief Data Officer ~$3k
    Showing the 40 most recent of 46 entries.
    The entity's full life in the product — typed, chronological, joined across Newspaper, Platform and Data. Our memory, made visible.
    Sources filings · IR · transcripts · market data · tier hybrid · as of 2026-08-04 Market data · Issuer disclosures · Public news · Earnings transcripts · Consensus estimates · ESG data Premium coverage